30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Forma Therapeutics Holdings Inc (FMTX)

Track

Stock chart
Ticker: FMTX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Wadlinger Mary E.
See Remarks
1 sale — total 45,798 USD
Sale 23 Feb 2022
Value US$211,169.75 | Price 133.46 | Shares 25,558
Sale 23 Feb 2022
Value US$2,877,986.29 | Price 148.59 | Shares 7,809
Sale 23 Feb 2022
Value US$175,809.23 | Price 9.78 | Shares 17,981
Sale 23 Feb 2022
Value US$55,604.64 | Price 9.78 | Shares 5,687
Sale 23 Feb 2022
Value US$51,282.99 | Price 9.78 | Shares 5,245
Sale 23 Feb 2022
Value US$45,680.48 | Price 9.78 | Shares 4,672
Sale 23 Feb 2022
Value US$34,524.35 | Price 9.78 | Shares 3,531
Buy 23 Jun 2020
Value US$20,000,000.00 | Price 20.00 | Shares 1,000,000
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 14,026
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 10,240
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 9,847
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 33,781
Buy 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 52,532
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 29,222
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 23,354
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 91,876
Buy 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 115,575
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 14,026
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 10,240
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 9,847
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 18,585
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 25,756
Buy 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 63,299
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 40,911
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 5,844
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 17,533
Buy 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 42,959
Buy 23 Jun 2020
Value US$80,000,000.00 | Price 20.00 | Shares 4,000,000
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 35,067
Buy 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 23,590
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 14,026
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 10,240
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 9,847
Sale 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 25,248
Buy 23 Jun 2020
Value US$0.00 | Price 0.00 | Shares 45,553
Buy 23 Jun 2020
Value US$80,000,000.00 | Price 20.00 | Shares 4,000,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-02-25 2022-02-23 S Sale
Wadlinger Mary E.

See Remarks

Officer
25,558 -33.9%
133.46
US$211,170 		25,558 -33.9% 133.46 US$211,170
2022-02-25 2022-02-23 S Sale
Lesser Brian Andrew

SVP, Commercial

Officer
7,809 -29.2%
148.59
US$2,877,986 		7,809 -29.2% 148.59 US$2,877,986
2022-02-25 2022-02-23 S Sale
3.7
Lee Frank D.

President and CEO

Executive Director
695 -35.9%
108.09
US$4,403,049 		695 -35.9% 108.09 US$4,403,049
2022-02-25 2022-02-23 S Sale
Shegog Todd

SVP, Chief Financial Officer

Officer
5,687 -20.0%
9.78
US$55,605 		5,687 -20.0% 9.78 US$55,605
2022-02-25 2022-02-23 S Sale
Kelly Patrick F.

SVP, Chief Medical Officer

Officer
5,245 -7.5%
9.78
US$51,283 		5,245 -7.5% 9.78 US$51,283
2022-02-25 2022-02-23 S Sale
1.7
Potts Jeannette

See Remarks

Officer
4,672 -17.3%
9.78
US$45,680 		4,672 -17.3% 9.78 US$45,680
2022-02-25 2022-02-23 S Sale
COOK DAVID N

SVP, Chief Scientific Officer

Officer
3,531 -17.7%
9.78
US$34,524 		3,531 -17.7% 9.78 US$34,524
2020-06-25 2020-06-23 B Purchase
3.0
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Large shareholder
1,000,000 +79.8%
20.00
US$20,000,000 		1,000,000 +79.8% 20.00 US$20,000,000
2020-06-24 2020-06-23 S Sale
Fanucci Marsha
Non-Executive Director
14,026
0.00
US$0 		14,026 0.00 US$0
2020-06-24 2020-06-23 S Sale
Fanucci Marsha
Non-Executive Director
10,240
0.00
US$0 		10,240 0.00 US$0
2020-06-24 2020-06-23 S Sale
Fanucci Marsha
Non-Executive Director
9,847
0.00
US$0 		9,847 0.00 US$0
2020-06-24 2020-06-23 S Sale
Fanucci Marsha
Non-Executive Director
33,781
0.00
US$0 		33,781 0.00 US$0
2020-06-24 2020-06-23 S Sale
Wadlinger Mary E.

See Remarks

Officer
29,222
0.00
US$0 		29,222 0.00 US$0
2020-06-24 2020-06-23 S Sale
Wadlinger Mary E.

See Remarks

Officer
23,354
0.00
US$0 		23,354 0.00 US$0
2020-06-24 2020-06-23 S Sale
Wadlinger Mary E.

See Remarks

Officer
91,876
0.00
US$0 		91,876 0.00 US$0
2020-06-24 2020-06-23 S Sale
0.5
WIRTH PETER
Non-Executive Director
14,026
0.00
US$0 		14,026 0.00 US$0
2020-06-24 2020-06-23 S Sale
0.5
WIRTH PETER
Non-Executive Director
10,240
0.00
US$0 		10,240 0.00 US$0
2020-06-24 2020-06-23 S Sale
0.5
WIRTH PETER
Non-Executive Director
9,847
0.00
US$0 		9,847 0.00 US$0
2020-06-24 2020-06-23 S Sale
0.5
WIRTH PETER
Non-Executive Director
18,585
0.00
US$0 		18,585 0.00 US$0
2020-06-24 2020-06-23 S Sale
0.5
WIRTH PETER
Non-Executive Director
25,756
0.00
US$0 		25,756 0.00 US$0
2020-06-24 2020-06-23 S Sale
Kelly Patrick F.

Chief Medical Officer

Officer
40,911
0.00
US$0 		40,911 0.00 US$0
2020-06-24 2020-06-23 S Sale
Kelly Patrick F.

Chief Medical Officer

Officer
5,844
0.00
US$0 		5,844 0.00 US$0
2020-06-24 2020-06-23 S Sale
Kelly Patrick F.

Chief Medical Officer

Officer
17,533
0.00
US$0 		17,533 0.00 US$0
2020-06-24 2020-06-23 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
4,000,000 +79.8%
20.00
US$80,000,000 		4,000,000 +79.8% 20.00 US$80,000,000
2020-06-24 2020-06-23 S Sale
3.1
CLACKSON TIMOTHY P
Non-Executive Director
35,067
0.00
US$0 		35,067 0.00 US$0
2020-06-24 2020-06-23 S Sale
Paoletti Paolo
Non-Executive Director
14,026
0.00
US$0 		14,026 0.00 US$0
2020-06-24 2020-06-23 S Sale
Paoletti Paolo
Non-Executive Director
10,240
0.00
US$0 		10,240 0.00 US$0
2020-06-24 2020-06-23 S Sale
Paoletti Paolo
Non-Executive Director
9,847
0.00
US$0 		9,847 0.00 US$0
2020-06-24 2020-06-23 S Sale
Paoletti Paolo
Non-Executive Director
25,248
0.00
US$0 		25,248 0.00 US$0
2020-06-24 2020-06-23 B Purchase
Kolchinsky Peter
Non-Executive Director Large shareholder
4,000,000 +79.8%
20.00
US$80,000,000 		4,000,000 +79.8% 20.00 US$80,000,000
2020-06-24 2020-06-23 B Purchase
Kelly Patrick F.

Chief Medical Officer

Officer
42,959
0.00
US$0 		42,959 0.00 US$0
2020-06-24 2020-06-23 B Purchase
0.5
WIRTH PETER
Non-Executive Director
63,299
0.00
US$0 		63,299 0.00 US$0
2020-06-24 2020-06-23 B Purchase
3.1
CLACKSON TIMOTHY P
Non-Executive Director
23,590
0.00
US$0 		23,590 0.00 US$0
2020-06-24 2020-06-23 B Purchase
Wadlinger Mary E.

See Remarks

Officer
115,575
0.00
US$0 		115,575 0.00 US$0
2020-06-24 2020-06-23 B Purchase
Fanucci Marsha
Non-Executive Director
52,532
0.00
US$0 		52,532 0.00 US$0
2020-06-24 2020-06-23 B Purchase
Paoletti Paolo
Non-Executive Director
45,553
0.00
US$0 		45,553 0.00 US$0
Explore more

More insider trading research around Forma Therapeutics Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America